cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Omega Therapeutics
9 own
7 watching
Current Price
$2.4
$-0.02
(-0.83%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
183.06M
52-Week High
52-Week High
10.09000
52-Week Low
52-Week Low
1.30000
Average Volume
Average Volume
0.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization183.06M
icon52-Week High10.09000
icon52-Week Low1.30000
iconAverage Volume0.4M
iconDividend Yield--
iconP/E Ratio--
What does the Omega Therapeutics do?
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature s operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Omega Therapeutics make?
News & Events about Omega Therapeutics.
Zolmax
1 year ago
Omega Therapeutics, Inc. (NASDAQ:OMGA Get Rating) Director Richard A. Young sold 5,000 shares of the firms stock in a transaction on Thursday, April 6th. The shares were sold at an average price of $8.00, for a total value of $40,000.00. Following the sale, the director now directly owns 749,118 ...
Ticker Report
1 year ago
Omega Therapeutics (NASDAQ:OMGA Get Rating) and Biogen (NASDAQ:BIIB Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst ...
Zolmax
1 year ago
Omega Therapeutics, Inc. (NASDAQ:OMGA Get Rating) major shareholder Flagship Pioneering Inc. bought 3,323,310 shares of Omega Therapeutics stock in a transaction dated Monday, February 27th. The stock was acquired at an average cost of $5.78 per share, with a total value of $19,208,731.80. Following...
Ticker Report
1 year ago
Omega Therapeutics, Inc. (NASDAQ:OMGA Get Rating) major shareholder Flagship Pioneering Inc. bought 3,323,310 shares of Omega Therapeutics stock in a transaction dated Monday, February 27th. The stock was acquired at an average cost of $5.78 per share, with a total value of $19,208,731.80. ...
PR Newswire
1 year ago
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
Frequently Asked Questions
Frequently Asked Questions
What is Omega Therapeutics share price today?
plus_minus_icon
Can Indians buy Omega Therapeutics shares?
plus_minus_icon
How can I buy Omega Therapeutics shares from India?
plus_minus_icon
Can Fractional shares of Omega Therapeutics be purchased?
plus_minus_icon
What are the documents required to start investing in Omega Therapeutics stocks?
plus_minus_icon
What is today’s traded volume of Omega Therapeutics?
plus_minus_icon
What is today’s market capitalisation of Omega Therapeutics?
plus_minus_icon
What is the 52-Week High and Low Range of Omega Therapeutics?
plus_minus_icon
What percentage is Omega Therapeutics down from its 52-Week High?
plus_minus_icon
What percentage is Omega Therapeutics up from its 52-Week Low?
plus_minus_icon
Current Price
$2.4
$-0.02
(-0.83%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00